Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A. Burger, Thomas J. Kipps, Carolyn Owen et al.|New England Journal of Medicine|2015Cited by 1.6k
Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus VenetoclaxLaura Eurelings, Mark‐David Levin, Emelie Curovic Rotbain et al.|Blood|2024Cited by 1